Marketing

Nerivio^® Drug-free Wearable Surpasses 100,000 Migraine Treatments in the US

ByDennis Dailey March 2, 2021March 3, 2026

M&A and Finance Marketing

EarlySense to Accelerate Growth in Remote Patient Monitoring Sector With Sale of Contact-Free Monitoring Technology To Hillrom

Read More EarlySense to Accelerate Growth in Remote Patient Monitoring Sector With Sale of Contact-Free Monitoring Technology To Hillrom
Innovation & Technology Marketing

Fairtility Expands European Market Penetration with CHLOE EQ, as Clinics in Five Countries Embrace Breakthrough AI Technology in IVF

Read More Fairtility Expands European Market Penetration with CHLOE EQ, as Clinics in Five Countries Embrace Breakthrough AI Technology in IVF
Business of Healthcare Marketing Partnerships

Exo and Henry Ford Health Partner to enable all Physicians with Point of Care Ultrasound

Read More Exo and Henry Ford Health Partner to enable all Physicians with Point of Care Ultrasound
Innovation & Technology Research

New Study Compares Remote Electrical Neuromodulation for Acute Treatment of Migraine to Treatment with Acute Medications

Headache Researchers in California and Missouri Conducted a Per-Patient Comparison of FDA-Cleared Wearable Device with Contemporary Usual Care Theranica,…

Read More New Study Compares Remote Electrical Neuromodulation for Acute Treatment of Migraine to Treatment with Acute Medications
Devices Innovation & Technology

FDA Approves Theranica’s Nerivio^® for Acute Treatment of Migraine in Adolescents

The Prescribed Wearable Device is Now indicated for Patients 12 Years Old and Above Theranica, a prescribed digital therapeutics (PDT)…

Read More FDA Approves Theranica’s Nerivio® for Acute Treatment of Migraine in Adolescents
Awards and Recognition Devices Digital Health

Nerivio Wins 2021 Medical Design Excellence Award

Read More Nerivio Wins 2021 Medical Design Excellence Award

Similar Posts